Novo Nordisk declined to comment on when the company would end production of human insulin pens, adding that the pens were ...

Novo Nordisk A/S, which faces higher demand for its ... The stock rose as much as 5.2% to a record in early trading.

Danish drugmaker Novo Nordisk's parent company, Novo Holdings, on Monday said it will acquire drug manufacturer Catalent in a $16.5 billion deal ... and injection pens, for Novo Nordisk's Wegovy.

In 2024’s third quarter, Novo’s total insulin sales clocked in at 12.5 billion Danish ... Novo Nordisk and Sanofi—to immediately cut the prices of their insulin pens to $1 per device in ...

Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’s next-gen obesity therapy ...

The $16.5 billion deal ... and the United States - onto Novo Nordisk for $11 billion. The sites will then by fully used by Novo Nordisk for filling its injection pens. Novo Holdings, Novo Nordisk ...

Meanwhile in South Africa, Novo Nordisk has decided to not renew a contract for human insulin pens. Clinicians are now ... would drop to $5.6 billion in 2030 from $7 billion last year, a 20% ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...